CDKN1A and prostate carcinoma: Upregulation of miR-370 promoted the G1/S cell cycle transition in prostate cancer cells, which correlated with downregulation of the cyclin-dependent kinase (CDK) inhibitors p27Kip1 and p21Cip1.